Home Healthcare Medical Devices Urology Care Devices and Platforms Market

Urology Care Devices and Platforms Market Size, Share & Trends Analysis Report By Products (Devices, Platforms), By Applications (Treatment, Diagnosis and Monitoring), By Indication (Kidney Diseases, Urological Cancer and Benign Prostatic Hyperplasia, Pelvic Organ Prolapse, Other Diseases), By End-User (Hospitals, Ambulatory Surgery Centers, and Clinics, Dialysis Centers, Homecare Settings) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Debashree B | Format: | Report Code: SR4352DR | Pages: 110
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Urology Care Devices and Platforms Market, By Products 2022-2034 (USD MILLION/ Units)
    1. Devices
    2. Platforms
  2. Urology Care Devices and Platforms Market, By Applications 2022-2034 (USD MILLION/ Units)
    1. Treatment
    2. Diagnosis and Monitoring
  3. Urology Care Devices and Platforms Market, By Indication 2022-2034 (USD MILLION/ Units)
    1. Kidney Diseases
    2. Urological Cancer and Benign Prostatic Hyperplasia
    3. Pelvic Organ Prolapse
    4. Other Diseases
  4. Urology Care Devices and Platforms Market, By End-User 2022-2034 (USD MILLION/ Units)
    1. Hospitals, Ambulatory Surgery Centers, and Clinics
    2. Dialysis Centers
    3. Homecare Settings
  5. Regional Urology Care Devices and Platforms Market
    1. North America
      1. North America Urology Care Devices and Platforms Market By Products 2022-2034 (USD MILLION/ Units)
        1. Devices
        2. Platforms
      2. North America Urology Care Devices and Platforms Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Treatment
        2. Diagnosis and Monitoring
      3. North America Urology Care Devices and Platforms Market By Indication 2022-2034 (USD MILLION/ Units)
        1. Kidney Diseases
        2. Urological Cancer and Benign Prostatic Hyperplasia
        3. Pelvic Organ Prolapse
        4. Other Diseases
      4. North America Urology Care Devices and Platforms Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals, Ambulatory Surgery Centers, and Clinics
        2. Dialysis Centers
        3. Homecare Settings
      5. U.S.
        1. Devices
        2. Platforms
        3. Treatment
        4. Diagnosis and Monitoring
        5. Kidney Diseases
        6. Urological Cancer and Benign Prostatic Hyperplasia
        7. Pelvic Organ Prolapse
        8. Other Diseases
        9. Hospitals, Ambulatory Surgery Centers, and Clinics
        10. Dialysis Centers
        11. Homecare Settings
      6. Canada
        1. Devices
        2. Platforms
        3. Treatment
        4. Diagnosis and Monitoring
        5. Kidney Diseases
        6. Urological Cancer and Benign Prostatic Hyperplasia
        7. Pelvic Organ Prolapse
        8. Other Diseases
        9. Hospitals, Ambulatory Surgery Centers, and Clinics
        10. Dialysis Centers
        11. Homecare Settings
    2. Europe
      1. Europe Urology Care Devices and Platforms Market By Products 2022-2034 (USD MILLION/ Units)
        1. Devices
        2. Platforms
      2. Europe Urology Care Devices and Platforms Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Treatment
        2. Diagnosis and Monitoring
      3. Europe Urology Care Devices and Platforms Market By Indication 2022-2034 (USD MILLION/ Units)
        1. Kidney Diseases
        2. Urological Cancer and Benign Prostatic Hyperplasia
        3. Pelvic Organ Prolapse
        4. Other Diseases
      4. Europe Urology Care Devices and Platforms Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals, Ambulatory Surgery Centers, and Clinics
        2. Dialysis Centers
        3. Homecare Settings
      5. U.K.
        1. Devices
        2. Platforms
        3. Treatment
        4. Diagnosis and Monitoring
        5. Kidney Diseases
        6. Urological Cancer and Benign Prostatic Hyperplasia
        7. Pelvic Organ Prolapse
        8. Other Diseases
        9. Hospitals, Ambulatory Surgery Centers, and Clinics
        10. Dialysis Centers
        11. Homecare Settings
      6. Germany
        1. Devices
        2. Platforms
        3. Treatment
        4. Diagnosis and Monitoring
        5. Kidney Diseases
        6. Urological Cancer and Benign Prostatic Hyperplasia
        7. Pelvic Organ Prolapse
        8. Other Diseases
        9. Hospitals, Ambulatory Surgery Centers, and Clinics
        10. Dialysis Centers
        11. Homecare Settings
      7. France
        1. Devices
        2. Platforms
        3. Treatment
        4. Diagnosis and Monitoring
        5. Kidney Diseases
        6. Urological Cancer and Benign Prostatic Hyperplasia
        7. Pelvic Organ Prolapse
        8. Other Diseases
        9. Hospitals, Ambulatory Surgery Centers, and Clinics
        10. Dialysis Centers
        11. Homecare Settings
      8. Spain
        1. Devices
        2. Platforms
        3. Treatment
        4. Diagnosis and Monitoring
        5. Kidney Diseases
        6. Urological Cancer and Benign Prostatic Hyperplasia
        7. Pelvic Organ Prolapse
        8. Other Diseases
        9. Hospitals, Ambulatory Surgery Centers, and Clinics
        10. Dialysis Centers
        11. Homecare Settings
      9. Italy
        1. Devices
        2. Platforms
        3. Treatment
        4. Diagnosis and Monitoring
        5. Kidney Diseases
        6. Urological Cancer and Benign Prostatic Hyperplasia
        7. Pelvic Organ Prolapse
        8. Other Diseases
        9. Hospitals, Ambulatory Surgery Centers, and Clinics
        10. Dialysis Centers
        11. Homecare Settings
      10. Russia
        1. Devices
        2. Platforms
        3. Treatment
        4. Diagnosis and Monitoring
        5. Kidney Diseases
        6. Urological Cancer and Benign Prostatic Hyperplasia
        7. Pelvic Organ Prolapse
        8. Other Diseases
        9. Hospitals, Ambulatory Surgery Centers, and Clinics
        10. Dialysis Centers
        11. Homecare Settings
      11. Nordic
        1. Devices
        2. Platforms
        3. Treatment
        4. Diagnosis and Monitoring
        5. Kidney Diseases
        6. Urological Cancer and Benign Prostatic Hyperplasia
        7. Pelvic Organ Prolapse
        8. Other Diseases
        9. Hospitals, Ambulatory Surgery Centers, and Clinics
        10. Dialysis Centers
        11. Homecare Settings
      12. Benelux
        1. Devices
        2. Platforms
        3. Treatment
        4. Diagnosis and Monitoring
        5. Kidney Diseases
        6. Urological Cancer and Benign Prostatic Hyperplasia
        7. Pelvic Organ Prolapse
        8. Other Diseases
        9. Hospitals, Ambulatory Surgery Centers, and Clinics
        10. Dialysis Centers
        11. Homecare Settings
      13. Rest of Europe
        1. Devices
        2. Platforms
        3. Treatment
        4. Diagnosis and Monitoring
        5. Kidney Diseases
        6. Urological Cancer and Benign Prostatic Hyperplasia
        7. Pelvic Organ Prolapse
        8. Other Diseases
        9. Hospitals, Ambulatory Surgery Centers, and Clinics
        10. Dialysis Centers
        11. Homecare Settings
    3. APAC
      1. APAC Urology Care Devices and Platforms Market By Products 2022-2034 (USD MILLION/ Units)
        1. Devices
        2. Platforms
      2. APAC Urology Care Devices and Platforms Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Treatment
        2. Diagnosis and Monitoring
      3. APAC Urology Care Devices and Platforms Market By Indication 2022-2034 (USD MILLION/ Units)
        1. Kidney Diseases
        2. Urological Cancer and Benign Prostatic Hyperplasia
        3. Pelvic Organ Prolapse
        4. Other Diseases
      4. APAC Urology Care Devices and Platforms Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals, Ambulatory Surgery Centers, and Clinics
        2. Dialysis Centers
        3. Homecare Settings
      5. China
        1. Devices
        2. Platforms
        3. Treatment
        4. Diagnosis and Monitoring
        5. Kidney Diseases
        6. Urological Cancer and Benign Prostatic Hyperplasia
        7. Pelvic Organ Prolapse
        8. Other Diseases
        9. Hospitals, Ambulatory Surgery Centers, and Clinics
        10. Dialysis Centers
        11. Homecare Settings
      6. Korea
        1. Devices
        2. Platforms
        3. Treatment
        4. Diagnosis and Monitoring
        5. Kidney Diseases
        6. Urological Cancer and Benign Prostatic Hyperplasia
        7. Pelvic Organ Prolapse
        8. Other Diseases
        9. Hospitals, Ambulatory Surgery Centers, and Clinics
        10. Dialysis Centers
        11. Homecare Settings
      7. Japan
        1. Devices
        2. Platforms
        3. Treatment
        4. Diagnosis and Monitoring
        5. Kidney Diseases
        6. Urological Cancer and Benign Prostatic Hyperplasia
        7. Pelvic Organ Prolapse
        8. Other Diseases
        9. Hospitals, Ambulatory Surgery Centers, and Clinics
        10. Dialysis Centers
        11. Homecare Settings
      8. India
        1. Devices
        2. Platforms
        3. Treatment
        4. Diagnosis and Monitoring
        5. Kidney Diseases
        6. Urological Cancer and Benign Prostatic Hyperplasia
        7. Pelvic Organ Prolapse
        8. Other Diseases
        9. Hospitals, Ambulatory Surgery Centers, and Clinics
        10. Dialysis Centers
        11. Homecare Settings
      9. Australia
        1. Devices
        2. Platforms
        3. Treatment
        4. Diagnosis and Monitoring
        5. Kidney Diseases
        6. Urological Cancer and Benign Prostatic Hyperplasia
        7. Pelvic Organ Prolapse
        8. Other Diseases
        9. Hospitals, Ambulatory Surgery Centers, and Clinics
        10. Dialysis Centers
        11. Homecare Settings
      10. Taiwan
        1. Devices
        2. Platforms
        3. Treatment
        4. Diagnosis and Monitoring
        5. Kidney Diseases
        6. Urological Cancer and Benign Prostatic Hyperplasia
        7. Pelvic Organ Prolapse
        8. Other Diseases
        9. Hospitals, Ambulatory Surgery Centers, and Clinics
        10. Dialysis Centers
        11. Homecare Settings
      11. South East Asia
        1. Devices
        2. Platforms
        3. Treatment
        4. Diagnosis and Monitoring
        5. Kidney Diseases
        6. Urological Cancer and Benign Prostatic Hyperplasia
        7. Pelvic Organ Prolapse
        8. Other Diseases
        9. Hospitals, Ambulatory Surgery Centers, and Clinics
        10. Dialysis Centers
        11. Homecare Settings
      12. Rest of Asia-Pacific
        1. Devices
        2. Platforms
        3. Treatment
        4. Diagnosis and Monitoring
        5. Kidney Diseases
        6. Urological Cancer and Benign Prostatic Hyperplasia
        7. Pelvic Organ Prolapse
        8. Other Diseases
        9. Hospitals, Ambulatory Surgery Centers, and Clinics
        10. Dialysis Centers
        11. Homecare Settings
    4. Middle East and Africa
      1. Middle East and Africa Urology Care Devices and Platforms Market By Products 2022-2034 (USD MILLION/ Units)
        1. Devices
        2. Platforms
      2. Middle East and Africa Urology Care Devices and Platforms Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Treatment
        2. Diagnosis and Monitoring
      3. Middle East and Africa Urology Care Devices and Platforms Market By Indication 2022-2034 (USD MILLION/ Units)
        1. Kidney Diseases
        2. Urological Cancer and Benign Prostatic Hyperplasia
        3. Pelvic Organ Prolapse
        4. Other Diseases
      4. Middle East and Africa Urology Care Devices and Platforms Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals, Ambulatory Surgery Centers, and Clinics
        2. Dialysis Centers
        3. Homecare Settings
      5. UAE
        1. Devices
        2. Platforms
        3. Treatment
        4. Diagnosis and Monitoring
        5. Kidney Diseases
        6. Urological Cancer and Benign Prostatic Hyperplasia
        7. Pelvic Organ Prolapse
        8. Other Diseases
        9. Hospitals, Ambulatory Surgery Centers, and Clinics
        10. Dialysis Centers
        11. Homecare Settings
      6. Turkey
        1. Devices
        2. Platforms
        3. Treatment
        4. Diagnosis and Monitoring
        5. Kidney Diseases
        6. Urological Cancer and Benign Prostatic Hyperplasia
        7. Pelvic Organ Prolapse
        8. Other Diseases
        9. Hospitals, Ambulatory Surgery Centers, and Clinics
        10. Dialysis Centers
        11. Homecare Settings
      7. Saudi Arabia
        1. Devices
        2. Platforms
        3. Treatment
        4. Diagnosis and Monitoring
        5. Kidney Diseases
        6. Urological Cancer and Benign Prostatic Hyperplasia
        7. Pelvic Organ Prolapse
        8. Other Diseases
        9. Hospitals, Ambulatory Surgery Centers, and Clinics
        10. Dialysis Centers
        11. Homecare Settings
      8. South Africa
        1. Devices
        2. Platforms
        3. Treatment
        4. Diagnosis and Monitoring
        5. Kidney Diseases
        6. Urological Cancer and Benign Prostatic Hyperplasia
        7. Pelvic Organ Prolapse
        8. Other Diseases
        9. Hospitals, Ambulatory Surgery Centers, and Clinics
        10. Dialysis Centers
        11. Homecare Settings
      9. Egypt
        1. Devices
        2. Platforms
        3. Treatment
        4. Diagnosis and Monitoring
        5. Kidney Diseases
        6. Urological Cancer and Benign Prostatic Hyperplasia
        7. Pelvic Organ Prolapse
        8. Other Diseases
        9. Hospitals, Ambulatory Surgery Centers, and Clinics
        10. Dialysis Centers
        11. Homecare Settings
      10. Nigeria
        1. Devices
        2. Platforms
        3. Treatment
        4. Diagnosis and Monitoring
        5. Kidney Diseases
        6. Urological Cancer and Benign Prostatic Hyperplasia
        7. Pelvic Organ Prolapse
        8. Other Diseases
        9. Hospitals, Ambulatory Surgery Centers, and Clinics
        10. Dialysis Centers
        11. Homecare Settings
      11. Rest of MEA
        1. Devices
        2. Platforms
        3. Treatment
        4. Diagnosis and Monitoring
        5. Kidney Diseases
        6. Urological Cancer and Benign Prostatic Hyperplasia
        7. Pelvic Organ Prolapse
        8. Other Diseases
        9. Hospitals, Ambulatory Surgery Centers, and Clinics
        10. Dialysis Centers
        11. Homecare Settings
    5. LATAM
      1. LATAM Urology Care Devices and Platforms Market By Products 2022-2034 (USD MILLION/ Units)
        1. Devices
        2. Platforms
      2. LATAM Urology Care Devices and Platforms Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Treatment
        2. Diagnosis and Monitoring
      3. LATAM Urology Care Devices and Platforms Market By Indication 2022-2034 (USD MILLION/ Units)
        1. Kidney Diseases
        2. Urological Cancer and Benign Prostatic Hyperplasia
        3. Pelvic Organ Prolapse
        4. Other Diseases
      4. LATAM Urology Care Devices and Platforms Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals, Ambulatory Surgery Centers, and Clinics
        2. Dialysis Centers
        3. Homecare Settings
      5. Brazil
        1. Devices
        2. Platforms
        3. Treatment
        4. Diagnosis and Monitoring
        5. Kidney Diseases
        6. Urological Cancer and Benign Prostatic Hyperplasia
        7. Pelvic Organ Prolapse
        8. Other Diseases
        9. Hospitals, Ambulatory Surgery Centers, and Clinics
        10. Dialysis Centers
        11. Homecare Settings
      6. Mexico
        1. Devices
        2. Platforms
        3. Treatment
        4. Diagnosis and Monitoring
        5. Kidney Diseases
        6. Urological Cancer and Benign Prostatic Hyperplasia
        7. Pelvic Organ Prolapse
        8. Other Diseases
        9. Hospitals, Ambulatory Surgery Centers, and Clinics
        10. Dialysis Centers
        11. Homecare Settings
      7. Argentina
        1. Devices
        2. Platforms
        3. Treatment
        4. Diagnosis and Monitoring
        5. Kidney Diseases
        6. Urological Cancer and Benign Prostatic Hyperplasia
        7. Pelvic Organ Prolapse
        8. Other Diseases
        9. Hospitals, Ambulatory Surgery Centers, and Clinics
        10. Dialysis Centers
        11. Homecare Settings
      8. Chile
        1. Devices
        2. Platforms
        3. Treatment
        4. Diagnosis and Monitoring
        5. Kidney Diseases
        6. Urological Cancer and Benign Prostatic Hyperplasia
        7. Pelvic Organ Prolapse
        8. Other Diseases
        9. Hospitals, Ambulatory Surgery Centers, and Clinics
        10. Dialysis Centers
        11. Homecare Settings
      9. Colombia
        1. Devices
        2. Platforms
        3. Treatment
        4. Diagnosis and Monitoring
        5. Kidney Diseases
        6. Urological Cancer and Benign Prostatic Hyperplasia
        7. Pelvic Organ Prolapse
        8. Other Diseases
        9. Hospitals, Ambulatory Surgery Centers, and Clinics
        10. Dialysis Centers
        11. Homecare Settings
      10. Rest of LATAM
        1. Devices
        2. Platforms
        3. Treatment
        4. Diagnosis and Monitoring
        5. Kidney Diseases
        6. Urological Cancer and Benign Prostatic Hyperplasia
        7. Pelvic Organ Prolapse
        8. Other Diseases
        9. Hospitals, Ambulatory Surgery Centers, and Clinics
        10. Dialysis Centers
        11. Homecare Settings
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.